The effects of intraovarian injection of autologous menstrual blood-derived mesenchymal stromal cells on pregnancy outcomes in women with poor ovarian response.
Simin ZafardoustSomaieh KazemnejadMina Fathi-KazerooniMaryam DarziMohammad Reza SadeghiAli Sadeghi TabarZahra SehatPublished in: Stem cell research & therapy (2023)
ClinicalTrials.gov Identifier: NCT05703308. Registered 01/26/2023, retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT05703308 . IRCT, IRCT20180619040147N4. Registered 08/01/2020.